Systems and methods for performing computer-simulated evaluation of treatments on a target population
Methods and systems may be used for performing computer-simulated evaluation of treatments. For example, the method may include: for each of a plurality of patients, receiving one or more patient-specific anatomical and/or physiological models; selecting, from the plurality of patients, a set of patients that have one or more common characteristics; for each patient in an experimental group, modifying at least one model of the respective one or more patient-specific models to obtain at least one modified patient-specific model that models an effect of an evaluation treatment on the respective patient, and calculating a value of an evaluation endpoint based on the respective at least one modified patient-specific model; and comparing the calculated values of the evaluation endpoint with one or more control values of the evaluation endpoint for patients that satisfy the one or more selection criterion.
1. A computer-implemented method for performing computer-simulated evaluation of treatments, the method comprising:
for each of a plurality of patients, receiving one or more patient-specific anatomical and/or physiological models, the one or more patient-specific models including a model of at least a portion of a vasculature of the respective patient;
selecting, from the plurality of patients, a set of patients that have one or more common characteristics;
identifying an experimental group of patients from the set of patients;
for each patient in the experimental group,
modifying at least one model of the respective one or more patient-specific models to obtain at least one modified patient-specific model that models an effect of an evaluation treatment on the respective patient, and
calculating a value of an evaluation endpoint based on the respective at least one modified patient-specific model, the evaluation endpoint being indicative of a health or medical characteristic of a patient; and
comparing the calculated values of the evaluation endpoint with one or more control values of the evaluation endpoint for patients that satisfy the one or more selection criterion.
2. The method of claim 1 , further comprising
identifying a control group of patients from the set of patients; and
calculating the control values of the evaluation endpoint by, for each patient in the control group of patients, calculating a control value of the evaluation endpoint based on the one or more patient-specific models received for the respective patient.
3. The method of claim 1 , wherein the evaluation treatment is one or more of: a revascularization, a surgery, a medication, weight gain or loss, organ transplantation, recanalization, a social policy change, a diet change, smoking cessation, a relocation, an environmental change, a genetic change, plaque regression or progression, immunotherapy, and use of a medical device or implant.
4. The method of claim 1 , wherein the evaluation endpoint is one or more of:
a fractional flow reserve (FFR);
an instantaneous wave-free ratio (iFR);
a coronary flow reserve (CFR);
a synergy between PCI with Taxus and Cardiac Surgery (SYNTAX) score;
a risk of major adverse cardiac events (MACE);
a percent stenosis;
an indicia, value, or characteristic of perfusion;
an indicia, value, or characteristic of plaque regression and/or progression; an indicia, value, or characteristic of plaque rupture; and
an indicia, value, or characteristic of thrombosis; and an indicia, value, or characteristic of organ function.
5. The method of claim 1 , wherein for each of the plurality of patients, the one or more patient-specific models further includes a patient-specific tissue model of a tissue of the respective patient.
6. The method of claim 5 , wherein
the vasculature is a coronary vasculature,
the tissue is a myocardial heart tissue, and
for each patient in the experimental group, the at least one modified patient-specific model is a modified vascular model obtained by modification of the respective model of the at least the portion of the vasculature.
7. The method of claim 6 , wherein
the one or more common characteristics includes having coronary artery disease,
the effect of the evaluation treatment is an opening of vascular sections with soft plaque, and
the evaluation endpoint is a value of fractional flow reserve (FFR) of at least a vessel portion of a vascular model.
8. The method of claim 7 , wherein
the one or more common characteristics includes an age characteristic,
the effect of the evaluation treatment is an increase of adispose tissue, and
the evaluation endpoint is rupture risk.
9. The method of claim 5 , wherein the evaluation endpoint is an indicia, value, or characteristic of perfusion in the tissue.
10. The method of claim 9 , wherein
the vasculature is a peripheral vasculature,
the tissue is a peripheral muscle tissue, and
the effect of the evaluation treatment is an increase in a systemic size of the peripheral vasculature.
11. The method of claim 1 , wherein
for each of the plurality of patients, the model of the at least the portion of the vasculature is a heart model,
the one or more common characteristics includes having a myocardial infarction,
the effect of the evaluation treatment is a usage of a pacemaker, and
the evaluation endpoint is an ejection fraction calculated using the heart model.
12. A computer system for performing computer-simulated evaluation of treatments, comprising:
a memory storing instructions;
one or more processors configured to execute the instructions to perform operations including:
for each of a plurality of patients, receiving one or more patient-specific anatomical and/or physiological models, the one or more patient-specific models including a model of at least a portion of a vasculature of the respective patient;
selecting, from the plurality of patients, a set of patients that have one or more common characteristics;
identifying an experimental group of patients from the set of patients;
for each patient in the experimental group,
modifying at least one model of the respective one or more patient-specific models to obtain at least one modified patient-specific model that models an effect of an evaluation treatment on the respective patient, and
calculating a value of an evaluation endpoint based on the respective at least one modified patient-specific model, the evaluation endpoint being indicative of a health or medical characteristic of a patient; and
comparing the calculated values of the evaluation endpoint with one or more control values of the evaluation endpoint for patients that satisfy the one or more selection criterion.
13. The computer system of claim 12 , wherein the operations further comprise:
identifying a control group of patients from the set of patients; and
calculating the control values of the evaluation endpoint by, for each patient in the control group of patients, calculating a control value of the evaluation endpoint based on the one or more patient-specific models received for the respective patient.
14. The computer system of claim 12 , wherein for each of the plurality of patients, the one or more patient-specific models includes a patient-specific tissue model of a tissue of the respective patient.
15. The computer system of claim 14 , wherein
the vasculature is a coronary vasculature, and
the tissue is a myocardial heart tissue, and
for each patient in the experimental group, the at least one modified patient-specific model is a modified vascular model obtained by modification of the respective model of the at least the portion of the vasculature.
16. The computer system of claim 15 , wherein
the one or more common characteristics includes having coronary artery disease,
the effect of the evaluation treatment is an opening of vascular sections with soft plaque, and
the evaluation endpoint is a value of fractional flow reserve (FFR) of at least a vessel portion of a vascular model.
17. The computer system of claim 16 , wherein
the one or more common characteristics includes an age characteristic,
the effect of the evaluation treatment is an increase of adispose tissue, and
the evaluation endpoint is rupture risk.
18. The computer system of claim 14 , wherein the evaluation endpoint is an indicia, value, or characteristic of perfusion in the tissue.
19. The computer system of claim 12 , wherein
for each of the plurality of patients, the model of the at least the portion of the vasculature is a heart model,
the one or more common characteristics includes having a myocardial infarction,
the effect of the evaluation treatment is a usage of a pacemaker, and
the evaluation endpoint is an ejection fraction calculated using the heart model.
20. A non-transitory computer-readable medium storing instructions that, when executed by one or more processors of a computer system, cause the one or more processors to perform a method for performing computer-simulated evaluation of treatments, the method comprising:
for each of a plurality of patients, receiving one or more patient-specific anatomical and/or physiological models, the one or more patient-specific models including a model of at least a portion of a vasculature of the respective patient;
selecting, from the plurality of patients, a set of patients that have one or more common characteristics;
identifying an experimental group of patients from the set of patients;
for each patient in the experimental group,
modifying at least one model of the respective one or more patient-specific models to obtain at least one modified patient-specific model that models an effect of an evaluation treatment on the respective patient, and
calculating a value of an evaluation endpoint based on the respective at least one modified patient-specific model, the evaluation endpoint being indicative of a health or medical characteristic of a patient; and
comparing the calculated values of the evaluation endpoint with one or more control values of the evaluation endpoint for patients that satisfy the one or more selection criterion.